Aerosolized liposomal rubitecan
aerosolized liposomal rubitecan An aerosolized liposomal preparation of a water-insoluble derivative of camptothecin with potential antineoplastic activity. 9-nitro-20 (S)-camptothecin and its active metabolite 9-aminocamptothecin (9-AC) selectively stabilize topoisomerase I-DNA covalent complexes during S-phase, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery. This agent is formulated with dilauroylphosphatidylcholine and nebulized in particle sizes of 1.2-1.6 micrometer mass median aerodynamic diameter.
Learn more about Aerosolized liposomal rubitecan
- Dailymed label info
- Scientific articles
- Drug portal Aerosolized liposomal rubitecan
- toxicity info on Aerosolized liposomal rubitecan
- FDA Aerosolized liposomal rubitecan